|Bid||36.30 x 800|
|Ask||38.03 x 800|
|Day's Range||38.02 - 38.48|
|52 Week Range||22.96 - 38.88|
|Beta (5Y Monthly)||1.66|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Portfolio Manager Lauren Romeo gives a comprehensive review of two key holdings in our Premier Quality Strategy Continue reading...
Colfax (CFX) is likely to gain from acquired assets, healthy medical technology business and emerging market exposure. High costs, forex woes and huge debts are concerns.
Matt Trerotola became the CEO of Colfax Corporation (NYSE:CFX) in 2015. This analysis aims first to contrast CEO...
Moody's Investors Service (Moody's) affirmed Colfax Corporation's (Colfax) corporate family rating at Ba2, the Probability of Default Rating at Ba2-PD and the senior unsecured ratings at Ba2. In addition, the Speculative Grade Liquidity rating was maintained at SGL-2. The rating actions also include Moody's expectations for the integration of DJO to continue progressing to plan as well as the anticipation that medical technology revenues will add resiliency to the top line while boosting margins and cash flow.
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They generate significant returns for investors to justify their large fees and they allocate a lot of time and employ complex research processes to determine the best stocks to invest in. A particularly […]
Colfax (CFX) benefits from acquisitions, productivity actions and product developments. However, escalating costs and a highly leveraged balance sheet are headwinds.
Apogee's (APOG) Q3 performance likely to reflect benefits from solid bidding and order activities, robust backlog, and an upbeat North America commercial construction market.
Cintas' (CTAS) fiscal second-quarter earnings are likely to have gained from strong prospects in Uniform Rental and Facility Services and First Aid and Safety Services segments.
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Hedge funds' top 3 stock picks returned 41.7% this year and beat […]
Colfax (CFX) is likely to continue benefiting from acquisitions, productivity actions and product developments. However, a highly leveraged balance sheet remains a concern.
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Granite Holdings US Acquisition Co. New York, November 14, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Granite Holdings US Acquisition Co. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.
It is doubtless a positive to see that the Colfax Corporation (NYSE:CFX) share price has gained some 32% in the last...
Colfax (CFX) delivered earnings and revenue surprises of 8.70% and -0.10%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Colfax Corporation and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing where to invest this money, as their own wealth also depends on it. Regardless of the various methods used by elite investors like David Tepper and David […]
Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
Colfax (CFX) is likely to gain from opportunities in fabrication technology and orthopedic solutions businesses, buyouts, and emerging market exposure. High costs, huge debts and forex woes are dragging.
IDEX (IEX) gains from a diversified business structure, solid product offerings, acquired assets and shareholder-friendly policies. Geopolitical uncertainties and forex woes are headwinds.
Anyone researching Colfax Corporation (NYSE:CFX) might want to consider the historical volatility of the share price...